Filing Details

Accession Number:
0001104659-20-000979
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-03 17:18:32
Reporting Period:
2019-12-23
Accepted Time:
2020-01-03 17:18:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1264587 Stemline Therapeutics Inc STML Pharmaceutical Preparations (2834) 450522567
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1456864 David Gionco C/O Stemline Therapeutics, Inc.
750 Lexington Avenue, Eleventh Floor
New York NY 10022
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-23 421 $10.58 239,517 No 4 S Direct
Common Stock Disposition 2019-12-24 2,388 $10.97 237,129 No 4 S Direct
Common Stock Disposition 2019-12-26 1,511 $10.75 235,618 No 4 S Direct
Common Stock Disposition 2019-12-27 197 $10.48 235,421 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. In connection with the vesting of 9,505 shares on December 21, 2019, a total of 4,517 shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies. 421 shares were sold on December 23, 2019; 2,388 shares were sold on December 24, 2019; 1,511 shares were sold on December 26, 2019; and 197 shares were sold on December 27, 2019.
  2. Reflects the weighted average sale price. The range of prices for the shares sold on December 23, 2019 was $10.37 to $10.75; the range of prices for the shares sold on December 24, 2019 was $10.81 to $11.15; the range of prices for the shares sold on December 26, 2019 was $10.52 to $11.20; and the range of prices for the shares sold on December 27, 2019 was $10.34 to $10.76. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Of the shares listed, 180,402 shares are restricted stock.